Megan Brooks April 21, 2023 An experimental neural cell therapy is safe and led to greater than 90% reduction in seizures in two patients with drug-resistant mesial temporal lobe epilepsy (MTLE) in the first-in-human test of the novel therapy. “It is notable that the early significant seizure reduction observed in this study appears to be durable in...